✦ LIBER ✦

RANDOMIZED TRIAL OF CONCURRENT CHEMORADIATION WITH CARBOPLATIN AND 5 FLUOROURACIL VERSUS CONCOMITANT BOOST IRRADIATION IN LOCALLY ADVANCED HEAD AND NECK CANCER

✍ Scribed by I. Chitapanarux; P. Kamnerdsupaphon

Book ID: 119518701
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 532 KB
Volume: 98
Category: Article
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(11)70081-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concurrent Chemoradiation with Carboplat

Concurrent Chemoradiation with Carboplatin and Paclitaxel with or without Concomitant Boost in Advanced Inoperable Head and Neck Cancers - Efficacy and Toxicity

✍ S.I. Temming; M. Kocher; J. Klussmann; S. Preuss; O. Guntinas-Lichius; R. Semrau 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 40 KB

1046 POSTER Dose escalation of daily car

1046 POSTER Dose escalation of daily carboplatin concurrent with accelerated radiation by delayed concomitant boost for locally advanced head and neck cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Phase I study of concomitant chemoradiat

Phase I study of concomitant chemoradiation with raltitrexed in locally advanced head and neck cancer

✍ A. Planting; M. de Jonge; P. Jansen; J. Kerrebijn; M. Smith; J.Verweij 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 242 KB

Concomitant boost radiotherapy with conc

Concomitant boost radiotherapy with concurrent weekly cisplatin in advanced head and neck cancers: a phase II trial

✍ Shaleen Kumar; Manish Pandey; Punita Lal; Neeraj Rastogi; K. Joseph Maria Das; K 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 101 KB

O28. Randomized phase II study of concom

O28. Randomized phase II study of concomitant chemoradiation using weekly carboplatin/paclitaxel/concomitant boost radiation with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced head and neck cancer

✍ Haddad, R.; Braschayko, P.; Sonis, S.; Posner, M.; Wirth, L.; Tishler, R. 📂 Article 📅 2009 🏛 Elsevier Science ⚖ 39 KB

Weekly 5-fluorouracil plus cisplatin for

Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancer

✍ Young Joo Lee; Chang Geol Lee; Byoung Chul Cho; Gwi Eon Kim; Hye Jin Choi; Eun C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

## Abstract ## Background. In locally advanced head and neck cancer, concurrent chemoradiotherapy (CRT) with combined 5‐fluorouracil (5‐FU) and cisplatin has increased acute toxicities as well as survival. Once‐weekly chemotherapeutic administration schedule may reduce severe toxicities. Thus, we